Background & Aims In 2017, the World Health Organization (WHO) designated
clarithromycin-resistant Helicobacter pylori a high priority for antibiotic research and …

Background Helicobacter pylori is one of the most prevalent global pathogens and can lead
to gastrointestinal disease including peptic ulcers, gastric marginal zone lymphoma and …

Important progress has been made in the management of Helicobacter pylori infection and
in this fifth edition of the Maastricht Consensus Report, key aspects related to the clinical role …

Data are available such that choice of Helicobacter pylori therapy for an individual patient
can be reliably predicted. Here, treatment success is defined as a cure rate of 90% or …

Objective To do a systematic review and meta-analysis of studies comparing sequential
therapy for eradication of Helicobacter pylori with pre-existing and new therapies, thus …

Helicobacter pylori infection causes chronic gastritis, which can progress to severe
gastroduodenal pathologies, including peptic ulcer, gastric cancer and gastric mucosa …

BACKGROUND & AIMS: Strategies to eradicate Helicobacter pylori infection could be
improved by suppressing acid and extending the duration of therapy (optimization). We …

Abstract Knowledge on the role of Helicobacter pylori (HP) infection is continually evolving,
and treatment is becoming more challenging due to increasing bacterial resistance. Since …

AIM: To determine the resistance patterns of Helicobacter pylori (H. pylori) strains isolated
from patients in Beijing and monitor the change of antibiotic resistance over time …

VI национальные рекомендации по диагностике и лечению кислотозависимых и
ассоциированных с Helicobacter pylori заболеваний (VI московские соглашения) – тема …